Results 1 to 10 of about 7,170 (116)
Case Report: Upadacitinib treatment for Behçet's syndrome with intestinal damage. [PDF]
Front Med (Lausanne)We report the case of a 17-year-old male presenting with recurrent, debilitating oral and genital ulcerations. Diagnostic evaluation confirmed multisystemic Behçet’s syndrome with multifocal intestinal involvement.
Yuan L, Sun Y, Yan J.
europepmc +2 more sources
Clusters in Behçet's syndrome. [PDF]
Arthritis Res Ther, 2022 Clustering is an important clinical feature of Behçet’s syndrome (BS) and may have pathogenetic and therapeutic implications. Recent and previous studies on BS phenotype differ substantially in terms of methodology.
İlgen U.
europepmc +2 more sources
Journal of Medical Case Reports, 2021 Background Behçet’s syndrome is a type of systemic chronic vasculitis of unknown etiology, frequently characterized by recurrent oral and genital ulcers and uveitis.
Ziyad Alakkas +4 more
doaj +1 more source
Gastrocnemius myositis associated with Behçet’s syndrome
European Journal of Case Reports in Internal Medicine, 2023 Behçet’s syndrome is a complex vasculitis involving vessels of all sizes. The typical clinical presentation consists of recurrent oral ulcers associated with genital ulcers, and/or intra-ocular inflammation and/or cutaneous lesions.
Christian Motet +2 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 A 33-year-old male patient with a 17-year Behcet’s syndrome history showed abdominal pain and fever symptoms. The abdominal CT was suggestive of an acute ileocecal intestinal perforation.
Jiewen Deng +5 more
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Vascular involvement is an infrequent clinical manifestation of Behçet’s syndrome. Owing to the rarity of arterial involvement in Behçet’s syndrome, there is limited experience in managing this phenomenon.
Hamed Ghoddusi Johari +4 more
doaj +1 more source
Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
Therapeutic Advances in Musculoskeletal Disease, 2022 Background: Intestinal Behçet’s syndrome is a major cause of morbidity and mortality in Behçet’s syndrome. Objectives: Current treatment challenges remain in refractory intestinal Behçet’s syndrome, when patients failed first and second-line therapies ...
Jun Zou +3 more
doaj +1 more source
Association of Sweet's syndrome and Behçet's disease: is it possible? A case report
European Journal of Case Reports in Internal Medicine, 2023 Introduction: Behçet's disease is a systemic vasculitis characterized by a large clinical polymorphism with a particular frequency of cutaneous signs. Sweet's syndrome is a neutrophilic dermatosis marked by the sudden appearance of painful skin lesions ...
El houcine El idrissi +3 more
doaj +1 more source
Egyptian Rheumatology and Rehabilitation, 2018 Background Insulin resistance is found in Behçet’s disease and associated with the development of metabolic syndrome. Our study explored whether amylin, which is involved in insulin resistance and development of metabolic syndrome, is observed in ...
Shimaa M Abdelwhab +3 more
doaj +1 more source
Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study
RMD Open, 2022 Objective To assess apremilast’s impact on patient quality of life (QoL) in active Behçet’s syndrome and correlations between improvement in patients’ QoL and efficacy measures in the phase 3 RELIEF study.Methods QoL measures included Behçet’s Disease ...
Gulen Hatemi +9 more
doaj +1 more source